Your Messages Inbox
Your Article Summary
See Latest ArticlesModernisation of Richter-Helm BioLogics’ Small-Scale GMP-Production Facility in Hannover completed
b3c newswire, 09/25/09
Richter–Helm's service portfolio for GMP compliant manufacturing of biopharmaceuticals roots in the Hannover facility. For more than 20 years, recombinant proteins, plasmid DNA and vaccines have been produced, which have met the extremely high quality standards for biopharmaceuticals. The construction work was completed in September and the new facility is presently undergoing qualification operations. After repeatedly improving its facility Richter–Helm has now clean rooms of class D up to class A in B available at the Hannover location, which where designed and constructed strictly following a GMP room concept.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
Article Search
Sponsor